SOURCE: Changing Times Vitamins

June 13, 2007 08:00 ET

Changing Times Vitamins Launches Its First Product

Company to Target the $35 Billion Cholesterol Market and $800 Million Glucosamine Market

SCOTTSDALE, AZ--(Marketwire - June 13, 2007) - Changing Times Vitamins, Inc. announced the launch of its first product today, ImmunePlusRx. The product targets individuals with weak immune systems due to a variety of medical problems, particularly high cholesterol, metabolic syndrome (a major indicator of inflammation and heart problems), and poor joints. The main ingredient in ImmunePlusRx is ProAlgaZyme, an all natural algae derivative that has gone though extensive clinical trials with excellent results. ProAlgaZyme is a product of Health Enhancement Products (OTCBB: HEPI).

In recent clinical trials, ProAlgaZyme (PAZ) reduced overall cholesterol by up to 32% and raised HDL, "Good Cholesterol" by up to 41%. PAZ has also had excellent results in reducing inflammation, a major effect of Arthritis. In a study just released by the University of Toronto in Ontario, Canada, glucosamine was shown to possibly slow bone turnover in arthritis sufferers.

Changing Times President Howard R. Baer stated, "We have taken one of the premier natural products known to man, ProAlgaZyme, and enhanced it by adding a non shellfish, non-animal derived glucosamine which is produced from a vegetarian source to aid in enhancing stronger bones and joints." Mr. Baer also stated that Changing Times intends to introduce at least two new products over the next several months, one of which will also be ProAlgaZyme based.

Contact Information